International Clinical Trial: A Study to Find Out How Effective and Safe JNJ-88545223 is for the Treatment of Participants with Active Psoriatic Arthritis (a Long-term Inflammatory Arthritis) (VELOTA)

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118186) titled 'A Study to Find Out How Effective and Safe JNJ-88545223 is for the Treatment of Participants with Active Psoriatic Arthritis (a Long-term Inflammatory Arthritis) (VELOTA)' on Feb. 3.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking University People's Hospital

Condition: Active Psoriatic Arthritis

Intervention: Control group:Placebo po qd (weeks 0 to 16) 100mg dose group:JNJ-88545223 100 mg po qd (weeks 0 to 16) 300mg dose group:JNJ-88545223 300 mg po qd (weeks 0 to 16)

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-02-28

Target Sample Size:...